METTL14 and hepatocellular carcinoma: These in vitro findings were further supported by limiting dilution assays and subcutaneous xenograft models, which demonstrated that METTL14-US significantly reduced the incidence of HCC cell xenografts in nude mice compared to METTL14-UL (Fig. 3H).